Sharecare Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Sharecare Inc (SHCR) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Sharecare Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 404M vs 868,302M combined for its competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-6.6% annualized vs trailing 12 months), vs decelerating (-17.1%) for its tracked peer group.
- Growth: Sharecare Inc generated -14.6% revenue growth year over year in Q2 2024, vs 6.4% for its competitors combined.
- Profitability: Its -44.6% net margin compares with 2.5% for the peer group.
- Peer revenue share: Sharecare Inc accounted for 0.1% of combined revenue among its tracked peer group, down from 0.1% a year earlier.
- Peer differentiation: Revenue per employee of $0.12M compares with $1.82M for the peer group (0.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
SHCR Sales vs. its Competitors, Q2 2024
Sharecare Inc reported revenue contraction of 14.58 % year on year in Q2 2024, below its competitors' combined revenue growth of 6.42 %.
With a net margin of -44.58 %, Sharecare Inc reported lower profitability than its competitors (2.46 %).
Sharecare Inc generated 0.05 % of the combined sales of its peer group, down from 0.07 % a year earlier.
API endpoints for this dataset
Sharecare Inc vs. its Competitors, Q2 2024
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Sharecare Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Sharecare Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Sharecare Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (6) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Sharecare Inc's competitor groups requires a Commercial License.
For context: the Medical Equipment & Supplies industry grew revenue 14.5% year over year, combined, vs -14.6% for Sharecare Inc. Sharecare Inc's share of combined industry revenue moved from 0.11% to 0.08%, a loss of 0.03 percentage points.
Sharecare Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Sharecare Inc | No | No | No | Yes |
| Competitors combined (13) | ||||
| Similar Growth & Profitability (8) | 0.00 % (0 of 8) | 12.50 % (1 of 8) | 0.00 % (0 of 8) | 37.50 % (3 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
SHCR Stock Performance relative to its Competitors
SHCR Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Lifestance Health Group Inc | 282.9% | Outperformed |
| 2 | American Well Corporation | 282.9% | Outperformed |
| 3 | Mckesson Corporation | 282.9% | Outperformed |
| 4 | Unitedhealth Group Incorporated | 282.9% | Outperformed |
| 5 | Teladoc Health Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Sharecare Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Sharecare Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Sharecare Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Sharecare Inc |
515.37 | 403.73 |
 Unitedhealth Group Incorporated |
355,523.30 | 449,662.00 |
 Mckesson Corporation |
126,452.13 | 410,983.00 |
 Lifestance Health Group Inc |
5,333.11 | 1,584.83 |
 Teladoc Health Inc |
1,595.05 | 2,468.14 |
 U S Physical Therapy Inc |
1,499.31 | 812.20 |
| SUBTOTAL | 492,002.48 | 870,015.86 |
Sign in to see all competitors of Sharecare Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Sharecare Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Sharecare Inc's Competitors Named by the Company
Competitive relationships identified from Sharecare Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| American Well Corporation | Company report | 85% |
| Uphealth Inc | Company report | 85% |
| Lifemd Inc | Company report | 85% |
| Cerner Corporation | Company report | 85% |
| Babylon Holdings Limited | Company report | 85% |
| Teladoc Health Inc | Company report | 85% |
| Veradigm Inc | Company report | 85% |
| Health Catalyst Inc | Company report | 85% |
| Unitedhealth Group Incorporated | Company report | 85% |
| U S Physical Therapy Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Sharecare Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Sharecare Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Unitedhealth Group Incorporated | UnitedHealthcare 76.61 % |
| Mckesson Corporation | North American Pharmaceutical 82.34 % |
| Teladoc Health Inc | Teladoc Health Integrated Care 65.85 % |
| U S Physical Therapy Inc | Physical Therapy Operations 85.19 % |
| Veradigm Inc | Provider 79.61 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sharecare Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Sharecare Inc | 515 | 120,444 | -40,729 |
| Unitedhealth Group Incorporated | 355,523 | 1,152,979 | 42,254 |
| Mckesson Corporation | 126,452 | 8,058,490 | 103,922 |
| Lifestance Health Group Inc | 5,333 | 144,588 | 4,616 |
| Teladoc Health Inc | 1,595 | 440,740 | -27,647 |
| U S Physical Therapy Inc | 1,499 | 111,352 | 6,837 |
| PEERS TOTAL | 491,487 | 1,819,306 | 42,487 |
Sharecare Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Teladoc Health Inc | United States 80.85 % |
| Veradigm Inc | US 99.91 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sharecare Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Medical Equipment & Supplies industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (342 companies). See the full Medical Equipment & Supplies industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 44.03 % | 46.17 % (avg) | -2.1 pp |
| Operating Margin | -35.40 % | industry median | -23.4 pp |
| EBITDA Margin | -3.41 % | -6.98 % (avg) | +3.6 pp |
| Capital Intensity (Capex / Revenue) | 7.27 % | 7.18 % (avg) | +0.1 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Sharecare Inc's Valuation vs Competitive Position
Valuation multiples vs the Medical Equipment & Supplies industry average (342 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Medical Equipment & Supplies industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 38.2x | - |
| EV / EBITDA | - | 18.1x | - |
| P/B | 0.7x | 4.6x | -3.9x |
| Return on Equity | -32.77 % | industry aggregate | -40.09 % |
| Return on Invested Capital | -16.69 % | -6.82 % (avg) | -9.87 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Sharecare Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue Growth | - | 7.02 % | 0.64 % |
| Operating Margin | -3.84 % | -31.50 % | -30.54 % |
| Return on Invested Capital | -2.34 % | -12.25 % | -14.30 % |
| P/E | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Sharecare Inc's Strategic Group Map
Sharecare Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
Sharecare Inc's trailing-12-month revenue growth of -13.1% and operating margin of -35.4% compares with an average of -7.6% growth and -35.9% margin across its 8 closest peers by combined growth, margin and ROIC -- Sharecare Inc sits below that peer average on growth and above it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Sharecare Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | Moderate, in line with the industry | Capital intensity (capex / revenue) of 7.27 % vs industry average 7.18 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Sharecare Inc's dedicated Suppliers and Customers pages, not here.
Sharecare Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Sharecare Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Sharecare Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Operating margin 23.4 points below the industry median.
- Return on equity 40.1 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-6.6% annualized vs trailing 12 months).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-17.1% annualized).
Methodology: see Methodology: SWOT Analysis.
Sharecare Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Sharecare Inc | 0.99 | 2.25 | 0.00 |
| Unitedhealth Group Incorporated | 0.23 | 0.81 | 0.73 |
| Mckesson Corporation | 0.07 | 0.88 | - |
| Lifestance Health Group Inc | 0.88 | 1.52 | 0.18 |
| Teladoc Health Inc | 0.88 | 1.28 | 0.75 |
| U S Physical Therapy Inc | 0.25 | 1.16 | 0.39 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Sharecare Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Sharecare Inc | Q2 2024 | -14.6 % | - |
| Unitedhealth Group Incorporated | Q3 2026 | -0.4 % | +61.6 % |
| Mckesson Corporation | Q2 2026 | +7.7 % | +24.2 % |
| Lifestance Health Group Inc | Q2 2026 | +26.1 % | - |
| Teladoc Health Inc | Q3 2026 | -3.4 % | - |
| U S Physical Therapy Inc | Q2 2026 | +8.5 % | -15.9 % |
| PEERS TOTAL | +3.4 % | +46.4 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Sharecare Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Sharecare Inc | Q2 2024 | -18.7 % | +5.5 % |
| Unitedhealth Group Incorporated | Q3 2026 | +9.1 % | -3.5 % |
| Mckesson Corporation | Q2 2026 | +7.6 % | -19.6 % |
| Lifestance Health Group Inc | Q2 2026 | - | +54.7 % |
| Teladoc Health Inc | Q3 2026 | +1.6 % | -2.5 % |
| U S Physical Therapy Inc | Q2 2026 | +10.5 % | +65.0 % |
Sharecare Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Sharecare Inc | - | - | - |
| Unitedhealth Group Incorporated | 5.30% | 8.29% | 15.97% |
| Mckesson Corporation | 6.43% | 35.05% | - |
| Lifestance Health Group Inc | 2.33% | 2.61% | 3.39% |
| Teladoc Health Inc | - | - | - |
| U S Physical Therapy Inc | 4.08% | 3.91% | 10.50% |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Sharecare Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Sharecare Inc | - | 1.28 |
| Unitedhealth Group Incorporated | 22.81 | 0.79 |
| Mckesson Corporation | 28.51 | 0.31 |
| Lifestance Health Group Inc | - | 3.37 |
| Teladoc Health Inc | - | 0.65 |
| U S Physical Therapy Inc | 180.89 | 1.85 |
| PEERS AVERAGE | 24.39 | 0.57 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.